Treatment of primary nonmetastatic melanoma at high-volume academic facilities is associated with improved long-term patient survival
- PMID: 30365997
- DOI: 10.1016/j.jaad.2018.10.026
Treatment of primary nonmetastatic melanoma at high-volume academic facilities is associated with improved long-term patient survival
Abstract
Background: Previous studies of cancer care have demonstrated improved long-term patient outcomes for those treated at high-volume centers. The influence of treatment center characteristics on outcomes for primary nonmetastatic melanoma is not currently established.
Objective: We aimed to investigate the association of cancer treatment center case volume and academic affiliation with long-term patient survival for cases of primary nonmetastatic melanoma.
Methods: Cases of melanoma diagnosed in US adults from 2004 to 2014 and included in the National Cancer Database were identified. Hospitals were grouped by yearly case-volume quartile: bottom quartile, 2 middle quartiles, and top quartile.
Results: Facility case volume was significantly associated with long-term patient survival (P < .0001). The 5-year survival rates were 76.8%, 81.9%, and 86.4% for patients treated at institutions in the bottom, middle, and top quartiles of case volume, respectively. On multivariate analysis, treatment at centers in both middle quartiles (hazard ratio, 0.834; 95% confidence interval, 0.778-0.895) and in the top quartile (hazard ratio, 0.691; 95% confidence interval, 0.644-0.741) of case volume was associated with improved survival relative to that of patients treated at hospitals in the bottom quartile of case volume. Academic affiliation was associated with improved outcomes for top-quartile- but not middle-quartile-volume facilities.
Limitations: Disease-specific survival was not available.
Conclusions: Treatment at a high-volume facility is associated with improved long-term patient survival for melanoma. High-volume academic centers have improved patient outcomes compared with other high-volume centers.
Keywords: NCDB; case volume; melanoma; outcomes; survival.
Copyright © 2018 American Academy of Dermatology, Inc. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Association of Treatment Facility Characteristics With Overall Survival After Mohs Micrographic Surgery for T1a-T2a Invasive Melanoma.JAMA Dermatol. 2021 May 1;157(5):531-539. doi: 10.1001/jamadermatol.2021.0023. JAMA Dermatol. 2021. PMID: 33787836 Free PMC article.
-
Treatment at high-volume facilities and academic centers is independently associated with improved survival in patients with locally advanced head and neck cancer.Cancer. 2017 Oct 15;123(20):3933-3942. doi: 10.1002/cncr.30843. Epub 2017 Jun 22. Cancer. 2017. PMID: 28640546
-
Association between facility volume and mortality of patients with classic Hodgkin lymphoma.Cancer. 2020 Feb 15;126(4):757-764. doi: 10.1002/cncr.32584. Epub 2019 Nov 12. Cancer. 2020. PMID: 31714588
-
The Impact of Academic Facility Type and Case Volume on Survival in Patients Undergoing Curative Radiation Therapy for Muscle-Invasive Bladder Cancer.Int J Radiat Oncol Biol Phys. 2018 Mar 15;100(4):851-857. doi: 10.1016/j.ijrobp.2017.11.040. Epub 2017 Dec 5. Int J Radiat Oncol Biol Phys. 2018. PMID: 29485062
-
The multidisciplinary melanoma center.Surg Clin North Am. 1996 Dec;76(6):1433-9. doi: 10.1016/s0039-6109(05)70525-9. Surg Clin North Am. 1996. PMID: 8977561 Review.
Cited by
-
High-volume facilities are significantly more likely to use guideline-adherent systemic immunotherapy for metastatic Merkel cell carcinoma: implications for cancer care regionalization.Arch Dermatol Res. 2024 Feb 13;316(3):86. doi: 10.1007/s00403-024-02817-4. Arch Dermatol Res. 2024. PMID: 38349538
-
Outcomes of stage IV melanoma in the era of immunotherapy: a National Cancer Database (NCDB) analysis from 2014 to 2016.J Immunother Cancer. 2022 Aug;10(8):e004994. doi: 10.1136/jitc-2022-004994. J Immunother Cancer. 2022. PMID: 35998982 Free PMC article.
-
Extent of Groin Dissection in Melanoma: A Mixed-Methods, Population-Based Study of Practice Patterns and Outcomes.Curr Oncol. 2021 Dec 16;28(6):5422-5433. doi: 10.3390/curroncol28060452. Curr Oncol. 2021. PMID: 34940091 Free PMC article.
-
Quality and Cost of Care by Hospital Teaching Status: What Are the Differences?Milbank Q. 2021 Mar;99(1):273-327. doi: 10.1111/1468-0009.12502. Milbank Q. 2021. PMID: 33751662 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical